AstraZeneca

AstraZeneca International is one of the world's leading pharmaceutical companies, producing quality prescription drugs and medicines. AstraZeneca was formed on April 6th, 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK.
AstraZeneca aims to discover new medicines to improve the health and quality of life of patients around the world. Their medicines are innovative, effective, and offer benefits such as reduced side effects or better ways of taking the treatment.

The company also focuses on getting the best from every medicine, by exploring all the ways it can be used or improved.

The mission of AstraZeneca is to deliver long term growth and enduring shareholder value through:

• Global power and reach in sales and marketing
• Stronger R&D platform for innovation-led growth
• Greater financial strategic flexibility

The main businesses of AstraZeneca are:

Health Care:

• Respiratory and Inflammation Therapy
• Infection Therapy
• Oncology Therapy
• Cardiovascular Therapy
• Neuroscience Therapy
• Gastrointestinal Therapy

Non pharmaceutical business:

• AstraTech
• Aptium Oncology (formerly Salick Health Care)

Key Statistics

• AstraZeneca holds assets of $23.72 billion.
• Profits made by AstraZeneca in 2006 amounted to $4.46 billion.
• AstraZeneca operates in countries of Europe, North and Central America, Latin America, Africa, Pacific, Asia, and the Middle East.
• AstraZeneca employs over 65,000 people worldwide.

Organizational Structure

The organization consists of:

• The Board
• Senior Executive Team
• Audit Committee
• Remuneration Committee
• Nomination Committee
• Science Committee

International Ranking

• AstraZeneca ranks 253rd in the world according to the Fortune Global 500 list.
• The Forbes Magazine ranked AstraZeneca 167th in the world in 2006.

The company has R&D centers and manufacturing sites in many parts of the world.

Headquarter Address:

15 Stanhope Gate
London W1K 1LN
United Kingdom
Phone: 44-20-7304-5000
Website URL: www.astrazeneca.com